Trial Profile

A phase 1 single-center, randomized, double-blind, placebo-controlled, ascending single- and multiple-dose study of Ozanimod in healthy volunteers

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 19 Apr 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ozanimod (Primary)
Indications Multiple sclerosis; Ulcerative colitis
Focus Adverse reactions; First in man; Pharmacodynamics; Pharmacokinetics

Most Recent Events

11 Apr 2017 Results published in the Journal of Clinical Pharmacology
18 May 2013 Results presented at the Digestive Disease Week 2013.
13 Oct 2012 Results presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com